Protocolo terapéutico del herpes genital y del herpes zóster

  1. Lanseros Tenllado, J. 1
  2. Arizcorreta Yarza, A. 1
  3. Correa Matos, M. 1
  4. Gerez Neira, D.V. 1
  1. 1 Servicio de Medicina Interna General, Enfermedades Infecciosas y Cuidados Paliativos, Hospital Universitario Puerta del Mar, Cádiz, España
Revue:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Année de publication: 2022

Titre de la publication: Enfermedades infecciosas (IX)

Serie: 13

Número: 57

Pages: 3375-3379

Type: Article

DIALNET GOOGLE SCHOLAR

D'autres publications dans: Medicine: Programa de Formación Médica Continuada Acreditado

Résumé

Genital herpes is a sexually transmitted infection with a worldwide distribution caused by herpes simplex virus type 2 and, to a lesser extent, type 1. It is characterized by recurrences, which can greatly affect the quality of life of people who experience them. There are two possible approaches to the disease: treatment of the episodes and its recurrences or chronic suppressive treatment. The varicella zoster virus causes two clinical diseases in human beings: the primary infection, consisting of varicella, and the reactivation of the virus in adult ages, known as herpes zoster. The first tends to be a mild disease in childhood and treatment with antiviral agents is only indicated in those older than 12 years of age or high-risk patients. The most common complication of the herpes zoster is postherpetic neuralgia and the most feared is ophthalmic involvement, due to its possible sequelae. Treatment with antiviral agents is especially indicated for patients older than 50 years or the at-risk population. Treatment must be individualized in the rest of cases.

Références bibliographiques

  • Ryder N, Jin F, McNulty AM, Grulich AE, Donovan B. Increasing role of herpes simplex virus type 1 in first-episode anogenital herpes in heterosexual women and younger men who have sex with men, 1992-2006. Sex Transm Infect. 2009;85:416-9.
  • Workowski KA, Bachmann LH, Chan PA, Chan PA, Johnston CM, Muzny CA. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;23:70:1-187.
  • Corey L, Wald A, Patel R, Sacks SL, Tyring SK, Warren T. Once daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med. 2004;350:11-20.
  • Kennedy P, Kennedy OJ, Clarke E, Geretti A, Nilsen A, Lautenschlager S. European Guidelines for the management of genital herpes. Int J STD AIDS. 2017;28:1366-79.
  • Richmond A, Pfieffer ML, Henry Okafor Q. Update on guidelines for sexually transmitted infection treatment and management in adults and adolescent population. Nurs Clin North Am. 2020;55:307-23.
  • de los Santos Moreno A, Jiménez Gallo D, Palomar Muñoz C, Montenegro Puche BE. Infecciones por virus del grupo herpes. Medicine. 2014; 11:2946-53.
  • Schmader K. Herpes zoster. Ann Intern Med. 2018;169:ITC19-ITC31.
  • Chen N, Li Q, Yang J, Zhou M, Zhou D, He L. Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst Rev. 2014;6: CD006866
La source de données: Dialnet